EUVIMEDEUVIMED entdecken
Crossref

Recombinant Methioninase Is Selectively Synergistic With Doxorubicin Against Wild-type Fibrosarcoma Cells Compared to Normal Cells and Overcomes Highly-Doxorubicin-resistant Fibrosarcoma

Sei Morinaga, Qinghong Han, Kohei Mizuta, Byung Mo Kang, Motokazu Sato, Michael Bouvet, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Takashi Higuchi und 3 weitere

Anticancer Research · 2024

DOI: 10.21873/anticanres.17144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Sei Morinaga und 14 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc., San Diego, CA, U.S.A. Hauptthemen laut MEDLINE: Doxorubicin, Fibrosarcoma, Carbon-Sulfur Lyases, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinFibrosarcomaCarbon-Sulfur LyasesDrug Resistance, NeoplasmDrug SynergismRecombinant ProteinsHumansCell Line, TumorAntibiotics, AntineoplasticFibroblasts

Stichwörter der Autor:innen

Hoffman effectMethioninasedoxorubicinfibrosarcomamethionine addictionmethionine restrictionnormal fibroblastsynergy

Substanzen

DoxorubicinCarbon-Sulfur LyasesL-methionine gamma-lyaseRecombinant ProteinsAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • AntiCancer Inc., San Diego, CA, U.S.A.
  • Department of Surgery, University of California, San Diego, CA, U.S.A.
  • Department of Orthopedic Surgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • AntiCancer Inc., San Diego, CA, U.S.A.; meishale@gmail.com.

Zitieren

APA

Morinaga, S., Han, Q., Mizuta, K., Kang, B. M., Sato, M., Bouvet, M., Yamamoto, N., Hayashi, K., Kimura, H., Miwa, S., Igarashi, K., Higuchi, T., Tsuchiya, H., Demura, S., & Hoffman, R. M. (2024). Recombinant Methioninase Is Selectively Synergistic With Doxorubicin Against Wild-type Fibrosarcoma Cells Compared to Normal Cells and Overcomes Highly-Doxorubicin-resistant Fibrosarcoma. Anticancer Research. https://doi.org/10.21873/anticanres.17144

Vancouver

Morinaga S, Han Q, Mizuta K, Kang BM, Sato M, Bouvet M, et al. Recombinant Methioninase Is Selectively Synergistic With Doxorubicin Against Wild-type Fibrosarcoma Cells Compared to Normal Cells and Overcomes Highly-Doxorubicin-resistant Fibrosarcoma. Anticancer Research. 2024. doi:10.21873/anticanres.17144

BibTeX
@article{Morinaga2024,
  author = {Morinaga, Sei and Han, Qinghong and Mizuta, Kohei and Kang, Byung Mo and Sato, Motokazu and Bouvet, Michael and Yamamoto, Norio and Hayashi, Katsuhiro and Kimura, Hiroaki and Miwa, Shinji and Igarashi, Kentaro and Higuchi, Takashi and Tsuchiya, Hiroyuki and Demura, Satoru and Hoffman, Robert M},
  title = {Recombinant Methioninase Is Selectively Synergistic With Doxorubicin Against Wild-type Fibrosarcoma Cells Compared to Normal Cells and Overcomes Highly-Doxorubicin-resistant Fibrosarcoma},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17144}
}
Kostenlos starten →